The effects of dissociatives can include sensory dissociation, hallucinations, mania, catalepsy, analgesia and amnesia. The characteristic features of dissociative anesthesia were described as catalepsy, amnesia and analgesia. According to Pender (1972), "the state has been designated as dissociative anesthesia since the patient truly seems disassociated from his environment." Bonta (2004) described dissociative anaesthesia as "... a peculiar anaesthetic state in which marked sensory loss and analgesia as well as amnesia is not accompanied by actual loss of consciousness." Both Pender (1970) and Johnstone et al. (1959) reported that patients under anaesthesia due to either ketamine or phencyclidine were prone to purposeless movements and had hallucinations (or "dreams") during and after anaesthesia. Some patients found the hallucinations euphoric while others found them disturbing.
^Tamminga, C. A.; Tanimoto, K.; Kuo, S.; Chase, T. N.; Contreras, P. C.; Rice, K. C.; Jackson, A. E.; O'Donohue, T. L. (1987). "PCP-induced alterations in cerebral glucose utilization in rat brain: Blockade by metaphit, a PCP-receptor-acylating agent". Synapse1 (5): 497–504. doi:10.1002/syn.890010514. PMID2850626.
^Giannini, AJ; Eighan, MS; Loiselle, RH; Giannini, MC (1984). "Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis". Journal of clinical pharmacology24 (4): 202–4. doi:10.1002/j.1552-4604.1984.tb01831.x. PMID6725621.
^Giannini, A. James; Nageotte, Catherine; Loiselle, Robert H.; Malone, Donald A.; Price, William A. (1984). "Comparison of Chlorpromazine, Haloperidol and Pimozide in the Treatment of Phencyclidine Psychosis: Da-2 Receptor Specificity". Clinical Toxicology22 (6): 573–9. doi:10.3109/15563658408992586. PMID6535849.
^Giannini, A. James; Giannini, Matthew C.; Price, William A. (1984). "Antidotal Strategies in Phencyclidine Intoxication". The International Journal of Psychiatry in Medicine14 (4): 315–21. doi:10.2190/KKAW-PWGF-W7RQ-23GN.
^Giannini, A. James; Price, William A.; Loiselle, Robert H.; Malone, Donald W. (1985). "Treatment of Phenylcyclohexylpyrrolidine (Php) Psychosis with Haloperidol". Clinical Toxicology23 (2-3): 185–9. doi:10.3109/15563658508990627. PMID4057312.
^Tarter, RE; Ammerman, RT; Ott, PJ (1998). Handbook of Substance Abuse: Neurobaehavioral Pharmacology. NY: Plenum Press. p. 265. ISBN0-306-45884-5.
^Mason, Oliver J.; Morgan, Celia J.M.; Stefanovic, Ana; Curran, H Valerie (2008). "The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis". Schizophrenia Research103 (1-3): 138–42. doi:10.1016/j.schres.2008.02.020. PMID18387788.
^Gouzoulis-Mayfrank, E.; Heekeren, K.; Neukirch, A.; Stoll, M.; Stock, C.; Obradovic, M.; Kovar, K.-A. (2005). "Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers". Pharmacopsychiatry38 (6): 301–11. doi:10.1055/s-2005-916185. PMID16342002.